Oncologic outcomes in rectal cancer with close distal resection margins: a retrospective analysis.
10.4174/astr.2015.89.1.23
- Author:
Kyung Sook HONG
1
;
Nara MOON
;
Soon Sup CHUNG
;
Ryung Ah LEE
;
Kwang Ho KIM
Author Information
1. Department of Surgery, Ewha Womans University School of Medicine, Seoul, Korea. eastgate@ewha.ac.kr
- Publication Type:Original Article
- Keywords:
Rectal neoplasms;
Local neoplasm recurrence;
Specimen;
Survival
- MeSH:
Chemoradiotherapy, Adjuvant;
Humans;
Medical Records;
Neoplasm Recurrence, Local;
Rectal Neoplasms*;
Recurrence;
Retrospective Studies*;
Survival Rate
- From:Annals of Surgical Treatment and Research
2015;89(1):23-29
- CountryRepublic of Korea
- Language:English
-
Abstract:
PURPOSE: The assurance of a negative resection margin is significant in rectal cancer as it indicates a reduced risk of local recurrence; thus, sufficient length of the resection margin is strongly required. The purpose of this study was to analyze the relationship between the length of the distal resection margin (DRM) and local recurrence or survival rate and to evaluate the possibility of performing sphincter-conserving surgery. METHODS: The medical records of 218 rectal cancer patients were analyzed. Patients were classified into three groups according to the length of the DRM as follows: group 1, DRM < 1 cm; group 2, 1 cm < or = DRM < or = 2 cm; and group 3, DRM > 2 cm. RESULTS: Of 218 patients enrolled, 81 were in group 1, 66 in group 2, and 71 in group 3. The 5-year survival rates were 78.2%, 78.2%, and 76.8% for groups 1, 2, and 3, respectively, and there were no statistically significant differences in survival (P = 0.913). Local recurrence was found in 2 patients in group 1, 1 patient in group 2, and 1 patient in group 3; there were no statistically significant differences in local recurrence (P = 0.908). CONCLUSION: A DRM of < 1 cm did not impair the oncologic outcomes of rectal cancer patients. Our results indicated that surgeons should keep in mind to consider the option of sphincter-conserving surgery with adjuvant chemoradiotherapy even in very low rectal cancer.
